122 related articles for article (PubMed ID: 32072245)
21. [Metanephric adenoma of the kidney. A clinicopathologic, immunohistochemical and electron microscopic study of two cases].
Martin L; Justrabo E; Michel F; Billerey C; Yaziji N
Ann Pathol; 1998 Apr; 18(2):120-4. PubMed ID: 9608864
[TBL] [Abstract][Full Text] [Related]
22. Two Cases of Renal Cell Carcinoma Harboring a Novel STRN-ALK Fusion Gene.
Kusano H; Togashi Y; Akiba J; Moriya F; Baba K; Matsuzaki N; Yuba Y; Shiraishi Y; Kanamaru H; Kuroda N; Sakata S; Takeuchi K; Yano H
Am J Surg Pathol; 2016 Jun; 40(6):761-9. PubMed ID: 26848800
[TBL] [Abstract][Full Text] [Related]
23. ALK-TPM3 rearrangement in adult renal cell carcinoma: Report of a new case showing loss of chromosome 3 and literature review.
Bodokh Y; Ambrosetti D; Kubiniek V; Tibi B; Durand M; Amiel J; Pertuit M; Barlier A; Pedeutour F
Cancer Genet; 2018 Feb; 221():31-37. PubMed ID: 29405994
[TBL] [Abstract][Full Text] [Related]
24. Integrin β3 Inhibition Enhances the Antitumor Activity of ALK Inhibitor in
Noh KW; Sohn I; Song JY; Shin HT; Kim YJ; Jung K; Sung M; Kim M; An S; Han J; Lee SH; Lee MS; Choi YL
Clin Cancer Res; 2018 Sep; 24(17):4162-4174. PubMed ID: 29776956
[No Abstract] [Full Text] [Related]
25. Metanephric adenoma during pregnancy: clinical presentation, histology, and cytogenetics.
Lerut E; Roskams T; Joniau S; Oyen R; Achten R; Van Poppel H; Debiec-Rychter M
Hum Pathol; 2006 Sep; 37(9):1227-32. PubMed ID: 16938529
[TBL] [Abstract][Full Text] [Related]
26. Metanephric adenoma of the kidney--a case report.
Mohanty SK; Arora R; Mandal AK; Kakkar N
Indian J Pathol Microbiol; 2003 Apr; 46(2):240-1. PubMed ID: 15022926
[TBL] [Abstract][Full Text] [Related]
27. [Metanephric Adenoma : A Report of Two Cases].
Kayano S; Sasaki H; Kimura T; Egawa S
Hinyokika Kiyo; 2018 Aug; 64(8):329-333. PubMed ID: 30369221
[TBL] [Abstract][Full Text] [Related]
28. Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in
Pailler E; Faugeroux V; Oulhen M; Mezquita L; Laporte M; Honoré A; Lecluse Y; Queffelec P; NgoCamus M; Nicotra C; Remon J; Lacroix L; Planchard D; Friboulet L; Besse B; Farace F
Clin Cancer Res; 2019 Nov; 25(22):6671-6682. PubMed ID: 31439588
[TBL] [Abstract][Full Text] [Related]
29. ALK-rearranged renal cell carcinomas in children.
Cajaiba MM; Jennings LJ; Rohan SM; Perez-Atayde AR; Marino-Enriquez A; Fletcher JA; Geller JI; Leuer KM; Bridge JA; Perlman EJ
Genes Chromosomes Cancer; 2016 May; 55(5):442-51. PubMed ID: 26773439
[TBL] [Abstract][Full Text] [Related]
30. ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literature.
Mamesaya N; Nakashima K; Naito T; Nakajima T; Endo M; Takahashi T
BMC Cancer; 2017 Jul; 17(1):471. PubMed ID: 28683775
[TBL] [Abstract][Full Text] [Related]
31. Relevance of Detection of Mechanisms of Resistance to ALK Inhibitors in ALK-Rearranged NSCLC in Routine Practice.
Jamme P; Descarpentries C; Gervais R; Dansin E; Wislez M; Grégoire V; Richard N; Baldacci S; Rabbe N; Kyheng M; Kherrouche Z; Escande F; Copin MC; Cortot AB
Clin Lung Cancer; 2019 Jul; 20(4):297-304.e1. PubMed ID: 31147208
[TBL] [Abstract][Full Text] [Related]
32. Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method.
Sugawara E; Togashi Y; Kuroda N; Sakata S; Hatano S; Asaka R; Yuasa T; Yonese J; Kitagawa M; Mano H; Ishikawa Y; Takeuchi K
Cancer; 2012 Sep; 118(18):4427-36. PubMed ID: 22252991
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants.
Cha YJ; Kim HR; Shim HS
J Transl Med; 2016 Oct; 14(1):296. PubMed ID: 27756333
[TBL] [Abstract][Full Text] [Related]
34. Histologic transformation of ALK-rearranged adenocarcinoma to squamous cell carcinoma after treatment with ALK inhibitor.
Park S; Han J; Sun JM
Lung Cancer; 2019 Jan; 127():66-68. PubMed ID: 30642554
[TBL] [Abstract][Full Text] [Related]
35. Small-cell transformation of
Balla A; Khan F; Hampel KJ; Aisner DL; Sidiropoulos N
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29317428
[TBL] [Abstract][Full Text] [Related]
36. Next generation sequencing reveals a novel ALK G1128A mutation resistant to crizotinib in an ALK-Rearranged NSCLC patient.
Ai X; Niu X; Chang L; Chen R; Ou SI; Lu S
Lung Cancer; 2018 Sep; 123():83-86. PubMed ID: 30089600
[TBL] [Abstract][Full Text] [Related]
37. Metanephric adenoma of the kidney.
Munichor M; Szvalb S; Cohen H
Urol Int; 1997; 58(2):117-20. PubMed ID: 9096275
[TBL] [Abstract][Full Text] [Related]
38. CT and ultrasound features of metanephric adenoma in adults with pathologic correlation.
Fielding JR; Visweswaran A; Silverman SG; Granter SR; Renshaw AA
J Comput Assist Tomogr; 1999; 23(3):441-4. PubMed ID: 10348452
[TBL] [Abstract][Full Text] [Related]
39. BRAF mutations in pediatric metanephric tumors.
Chami R; Yin M; Marrano P; Teerapakpinyo C; Shuangshoti S; Thorner PS
Hum Pathol; 2015 Aug; 46(8):1153-61. PubMed ID: 26014474
[TBL] [Abstract][Full Text] [Related]
40. The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC).
Golding B; Luu A; Jones R; Viloria-Petit AM
Mol Cancer; 2018 Feb; 17(1):52. PubMed ID: 29455675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]